SEC 13F Intelligence

Rtw Investments, LP / PMVP

Rtw Investments, LP’s Pmv Pharmaceuticals Inc Position

Does Rtw Investments, LP own Pmv Pharmaceuticals Inc (PMVP)? Not currently — the last reported position was 2.38M shares worth $15M in Q3 2023; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$15M
Q3 2023
Shares
2.38M
% of Portfolio
+0.31%
Quarters Held
13
position exited

Position History PMVP

Reported value by quarter
Q3 ’20: $18MQ3 ’20Q4 ’20: $31MQ1 ’21: $16MQ1 ’21Q2 ’21: $17MQ3 ’21: $24MQ3 ’21Q4 ’21: $69MQ1 ’22: $81MQ1 ’22Q2 ’22: $63MQ3 ’22: $52MQ3 ’22Q4 ’22: $38MQ1 ’23: $14MQ1 ’23Q2 ’23: $19MQ3 ’23: $15MQ3 ’23filingsflow.com
QuarterSharesValue% of Portfolio
Q3 20232.38M$15M+0.31%
Q2 20233.03M$19M+0.36%
Q1 20233.00M$14M+0.30%
Q4 20224.36M$38M+0.77%
Q3 20224.36M$52M+1.20%
Q2 20224.40M$63M+1.62%
Q1 20223.87M$81M+1.67%
Q4 20212.98M$69M+1.01%
Q3 2021809.9K$24M+0.36%
Q2 2021484.1K$17M+0.25%
Q1 2021484.1K$16M+0.25%
Q4 2020500.9K$31M+0.52%
Q3 2020500.0K$18M+0.43%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Rtw Investments, LP’s full portfolio or all institutional holders of PMVP.